Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis

BACKGROUND: The Respiratory Syncytial Virus (RSV) Respiratory Events Among Preterm Infants Outcomes and Risk Tracking (REPORT) study evaluated RSV disease burden in US preterm infants 32–35 weeks gestational age (wGA) not receiving RSV prophylaxis. METHODS: Preterm infants <6 months of age as of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, Christopher S., Anderson, Evan J., Simões, Eric A. F., Wu, Xionghua, Elhefni, Hanaa, Park, C. Lucy, Sifakis, Frangiscos, Groothuis, Jessie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2014
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025592/
https://www.ncbi.nlm.nih.gov/pubmed/24622396
http://dx.doi.org/10.1097/INF.0000000000000219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025592/
https://www.ncbi.nlm.nih.gov/pubmed/24622396
http://dx.doi.org/10.1097/INF.0000000000000219

Ejemplares similares